Cancer Immunotherapy By Delivering Class II MHC Antigens Using a VLP Replicon Read more about Cancer Immunotherapy By Delivering Class II MHC Antigens Using a VLP Replicon US Application 61/916,394Filed on 2013-12-16
Multi-Epitope TARP Peptide Vaccine And Uses Thereof Read more about Multi-Epitope TARP Peptide Vaccine And Uses Thereof US Application 61/915,948Filed on 2013-12-13
4-Benzyl-Amino-Benzyl-Alcohol Anti-Cancer Agents Read more about 4-Benzyl-Amino-Benzyl-Alcohol Anti-Cancer Agents US Application 61/933,606Filed on 2014-01-30
IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES Read more about IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES US Application 61/820,035Filed on 2013-05-06
Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same Read more about Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same US Application 61/912,948Filed on 2013-12-06
IMMUNOGENIC JC POLYOMAVIRUS COMPOSITIONS AND METHODS OF USE Read more about IMMUNOGENIC JC POLYOMAVIRUS COMPOSITIONS AND METHODS OF USE US Application 61/919,043Filed on 2013-12-20
Modified Pseudomonas Exotoxin A Read more about Modified Pseudomonas Exotoxin A US Application 61/908,464Filed on 2013-11-25
ALK1 ANTIBODIES, CONJUGATES THEREOF, AND THEIR USE Read more about ALK1 ANTIBODIES, CONJUGATES THEREOF, AND THEIR USE US Application 61/900,806Filed on 2013-11-06
COMPOUNDS THAT BIND TO HIV-1 REV RESPONSE ELEMENTT Read more about COMPOUNDS THAT BIND TO HIV-1 REV RESPONSE ELEMENTT US Application 61/894,849Filed on 2013-10-23
Modified Pseudomonas Exotoxin A Read more about Modified Pseudomonas Exotoxin A US Application 61/887,418Filed on 2013-10-06